Protein kinase Mzeta has been the subject of much recent interest, as it is the only molecule currently identified to maintain memory. Despite the wealth of studies investigating PKMf in memory, questions remain about which types of memory PKMf supports. Further, it is unclear how long the inhibitor of PKMz, f-pseudosubstrate inhibitory peptide (ZIP) remains in the brain after infusion. Here, we demonstrate that foreground context fear memory requires PKMf activity in the amygdala. We also show that ZIP is fully cleared from the brain by 24 h after infusion. These data contribute to a growing body of literature that demonstrates that PKMf plays a key role in maintaining amygdala-dependent memory and provides new information about the degradation timecourse of the most commonly used inhibitor of PKMf, ZIP.
Introduction
Protein kinase Mzeta (PKMf) is an atypical isoform of protein kinase C (PKC) that has attracted intense interest in the past few years for its putative role in memory maintenance. PKMf lacks the autoinhibitory domain that accompanies other PKC isoforms, allowing the molecule to remain constitutively active. The constant activity of PKMf is believed to actively maintain the synaptic changes that occurred during memory formation, particularly the upregulation of AMPA receptors through the NSF-GluR2 pathway (Migues et al., 2010; Sacktor, 2010; Yao et al., 2008) . Inhibition of PKMf with zeta pseudosubstrate inhibitory peptide (ZIP) can disrupt established memories for a number of learning tasks (Hardt, Migues, Hastings, Wong, & Nader, 2009; Kwapis, Jarome, Lonergan, & Helmstetter, 2009; Pastalkova et al., 2006; Serrano et al., 2008; Shema, Sacktor, & Dudai, 2007) , consistent with the idea that PKMf supports memory maintenance.
Interestingly, it seems that not all forms of memory require PKMf activity for maintenance. For example, ''background'' fear conditioning to the training context (acquired during a session in which a discrete conditional stimulus (CS), such as a white noise cue, is paired with an aversive unconditional stimulus (UCS), such as a shock) is not disrupted by PKMf inhibition in the hippocampus, although hippocampal lesions disrupt this type of background context memory (Kwapis et al., 2009; Serrano et al., 2008) . Hippocampal infusions of ZIP, however, are sufficient to disrupt object location memory (Hardt et al., 2009) , and other spatial memories, like active avoidance memory and memory for the 8-arm radial arm maze (Pastalkova et al., 2006; Serrano et al., 2008) . These studies demonstrate a clear need to assess the role of PKMf in different forms of memory, particularly those that involve contextual, background, or procedural components.
More recent findings suggest that PKMf inhibition may only temporarily disrupt memory expression of fear-potentiated startle, rather than permanently erasing the memory (Parsons & Davis, 2011) . In this study, a test 10 d after ZIP infusion had showed no effect of the drug on memory retention despite the same infusion producing profound memory deficits when animals were tested at both 1 d and 10 d after ZIP infusion. Another recent study, however, demonstrated a deficit in active avoidance responses when the memory was tested 7 d after ZIP infusion (Gamiz & Gallo, 2011) . Further, many of the previous studies testing the effects of ZIP on memory maintenance use a short injection-to-initial test interval, although it is unknown how long ZIP persists in brain tissue after infusion. It is possible that the initial test in these studies occurs while ZIP is still present in brain tissue and that memory expression or retrieval is impaired, rather than memory maintenance. In order to rule out the possibility that the peptide disrupts fear expression, and to clarify the results of previous studies using ZIP to inhibit PKMf, it is important to know when the peptide is fully metabolized from brain tissue.
The objectives of this study were twofold. First, we wanted to determine whether PKMf activity in the amygdala is required to
